1. Home
  2. GHRS vs CGNT Comparison

GHRS vs CGNT Comparison

Compare GHRS & CGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • CGNT
  • Stock Information
  • Founded
  • GHRS 2018
  • CGNT 2020
  • Country
  • GHRS Ireland
  • CGNT Israel
  • Employees
  • GHRS N/A
  • CGNT N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • CGNT Computer Software: Prepackaged Software
  • Sector
  • GHRS Health Care
  • CGNT Technology
  • Exchange
  • GHRS Nasdaq
  • CGNT Nasdaq
  • Market Cap
  • GHRS 583.1M
  • CGNT 669.2M
  • IPO Year
  • GHRS 2021
  • CGNT N/A
  • Fundamental
  • Price
  • GHRS $12.03
  • CGNT $10.91
  • Analyst Decision
  • GHRS Strong Buy
  • CGNT Hold
  • Analyst Count
  • GHRS 8
  • CGNT 2
  • Target Price
  • GHRS $30.63
  • CGNT $9.00
  • AVG Volume (30 Days)
  • GHRS 149.3K
  • CGNT 231.4K
  • Earning Date
  • GHRS 05-08-2025
  • CGNT 06-11-2025
  • Dividend Yield
  • GHRS N/A
  • CGNT N/A
  • EPS Growth
  • GHRS N/A
  • CGNT N/A
  • EPS
  • GHRS N/A
  • CGNT N/A
  • Revenue
  • GHRS N/A
  • CGNT $350,632,000.00
  • Revenue This Year
  • GHRS N/A
  • CGNT $13.87
  • Revenue Next Year
  • GHRS N/A
  • CGNT $9.64
  • P/E Ratio
  • GHRS N/A
  • CGNT N/A
  • Revenue Growth
  • GHRS N/A
  • CGNT 11.88
  • 52 Week Low
  • GHRS $6.00
  • CGNT $6.21
  • 52 Week High
  • GHRS $20.50
  • CGNT $11.12
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 58.82
  • CGNT 69.98
  • Support Level
  • GHRS $10.66
  • CGNT $10.42
  • Resistance Level
  • GHRS $13.00
  • CGNT $10.98
  • Average True Range (ATR)
  • GHRS 0.96
  • CGNT 0.39
  • MACD
  • GHRS 0.12
  • CGNT 0.04
  • Stochastic Oscillator
  • GHRS 67.84
  • CGNT 87.24

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About CGNT Cognyte Software Ltd.

Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.

Share on Social Networks: